Title | The first identified mutation associated to Alternating Hemiplegia of Childhood (AHC) in a Greek family: clinical and genetical approach | ||
Authors | K. Nazos1,2, M.-T. Bassi1, N. Bresolin1 and K. Pantos2
1. Stem-cells Laboratory, Neurological Clinic, Medical School, University of Milan, Milan, Italy 2. Pharmacological Department, Medical School, University of Athens, Athens, Greece |
||
Citation | Nazos, K., Bassi, M.-T., Bresolin, N., Pantos, K.: The first identified mutation associated to Alternating Hemiplegia of Childhood (AHC) in a Greek family: clinical and genetical approach, Epitheorese Klin. Farmakol. Farmakokinet. 22(2): 256-258 (2008) | ||
Publication Date | 23-25 May 2008 | ||
Full Text Language | English | ||
Order – Buy | Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)
pharmakonpress[at]pharmakonpress[.]gr |
||
Keywords | Alternating Hemiplegia of Childhood, AHC, Greek family, clinical, genetical approach. | ||
Other Terms | Review article | ||
Summary | – | ||
References | 1. Ducros A., et al.: Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann. Neurol. 42: 585590 (1997)
2. Lance J.W.: Is alternating hemiplegia of childhood (AHC) a variant of migraine? Cephalalgia 20: 685 (2000) 3. Price E.M., Rice D.A., Lingrel J.B.: Stusture-function studies of Na,K-ATPase. Site directed mutagenesis of the border residues from H1-H2 extracellular domain of the α subunit. J. Biol. Chem. 265: 6638-6641 (1990) 4. Tottene A., et al.: Familial hemiplegic migraine mutations increase Ca influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc. Natl. Acad. Sci. USA 99: 13284-13289 (2002) 5. Mikati M.A., Maguire H., Barlow C.F., Ozelius L. Breakefield X.O., Klauck S.M., Korf B., O’Tuama S.L., Dangond F. A syndrome of autosomal dominant alternating hemiplegia: Clinical presentation mimicking intractable epilepsy; chromosomal studies and physiologic investigations. Neurology 42: 2251-2257 (1992) 6. Mikati M.A., Kramer U., Zupanc M.L., Shanahan R.J.: Alternating hemiplegia of chilhood: clinical manifestations and long term outcome. Pediatr. Neurol. 23: 134-141 (2000) 7. Hu Y.K., Kaplan J.H.: Site-directed chemical labeling of extracellular loops in a membrane protein. The topology of the Na,K-ATPase, a subunit. J. Biol. Chem. 275: 19185-19191 (2000) 8. Petersen P.A., Rasmussen J.H., Jorgensen P.L.: Consequences of mutations to the phosphorylation site of the alpha-subunit of Na,K-ATPase for ATP binding and E1-E2 conformational equilibrium. Biochemistry 35(50): 16085-16093 (1996) 9. Juhaszova M., Blaustein M.P.: Na pump low and high ouabain affinity alpha subunit isoforms are differently described in cells. Proc. Natl. Acad. Sci. USA 94: 1800-1805 (1997) 10. Blau J.N., Whitty C.: Familial hemiplegic migraine. Lancet 2: 1115-1116 (1955) 11. Ophoff R.A., et al.: Familial hemiplegic migraine and episodic ataxis type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87: 543-552 (1996) 12. De Fusco M., Marconi R., Silvestri L. Atorino L., Rampoldi L., Morgante L., Balladio A., Aridon P., Casari G.: Haploinsufficiency of ATP1A2 encoding the Na/K pump alpha2 subunit associated with familial hemiglegic migraine type 2. Nat. Genet. 33: 192-196 (2003) 13. Sakuntabhai A., et al.: Mutations in ATP2A2 encoding a Ca pump, cause Darier disease. Nat. Genet. 21: 271-277 (1999) |
||
Relative Papers |
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
- Chemical Abstracts
- Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Συντακτικη Επιτροπή-Editorial Board
ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2008 – ANNUAL SUBSCRIPTION 2008 | |
Γλώσσα Πλήρους Κειμένου – Full Text Language | Αγγλικά – English |
Παραγγελία – Αγορά – Order – Buy | Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr |
Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr |